A common haplotype of the dopamine transporter gene associated with attention-deficit/hyperactivity disorder and interacting with maternal use of alcohol during pregnancy

Archives of General Psychiatry

Volumn 63, Issue 1, 2006, Pages 74-81

  Brookes, Keeley Joanne ^a   Mill, Jon ^a   Guindalini, Camilla ^a   Curran, Sarah ^a   Xu, Xiaohui ^a   Knight, Jo ^a   Chen, Chih Ken ^b   Huang, Yu Shu ^b   Sethna, Vaheshta ^a   Taylor, Eric ^a   Chen, Wai ^a   Breen, Gerome ^a   Asherson, Philip ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; DOPAMINE TRANSPORTER;

3' UNTRANSLATED REGION; ADOLESCENT; ALCOHOL ABUSE; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CHILD BEHAVIOR; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE TRANSMISSION; DNA POLYMORPHISM; DOPAMINE TRANSPORTER GENE; ENVIRONMENTAL FACTOR; FEMALE; GENE; GENETIC MARKER; GENOTYPE ENVIRONMENT INTERACTION; HAPLOTYPE; HETEROZYGOTE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; MATERNAL BEHAVIOR; PARENT; PLACENTAL TRANSFER; PREGNANCY; PROGENY; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; TAIWAN; TANDEM REPEAT;

ALCOHOL DRINKING; ASIAN CONTINENTAL ANCESTRY GROUP; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHROMOSOME MAPPING; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; ENGLAND; ETHANOL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MATERNAL EXPOSURE; MATERNAL-FETAL EXCHANGE; PREGNANCY; PREGNANCY COMPLICATIONS; PROSPECTIVE STUDIES; RISK FACTORS; SMOKING; TAIWAN;

EID: 29844456031     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archpsyc.63.1.74     Document Type: Article

References (65)

1. Ford T, Goodman R, Meltzer H. The British Child and Adolescent Mental Health Survey 1999. J Am Acad Child Adolesc Psychiatry. 2003;42:1203-1211.
2. Levy F, Hay D. Attention, Genes and ADHD. London, England: Brunner-Routledge; 2001.
3. Pineda DA, Lopera F, Palacio JD, Ramirez D, Henao GC. Prevalence estimations of attention deficit hyperactivity disorder. Int J Neurosci. 2003;113:49-71.
4. Faraone SV, Biederman J, Spencer T, Wilens T, Seidman LJ, Mick E, Doyle AE. Attention deficit hyperactivity disorder in adults: an overview. Biol Psychiatry. 2000;48:9-20.
5. Thapar A, Holmes J, Poulton K, Harrington R. Genetic basis of attention deficit and hyperactivity. Br J Psychiatry. 1999;174:105-111.
6. Rutter M, Silberg J. Gene-environment interplay in relation to emotional and behavioural disturbance. Annu Rev Psychol. 2002;53:463-490.
7. Asherson P; IMAGE Consortium. Attention-deficit hyperactivity disorder in the post-genomic era. Eur Child Adolesc Psychiatry. 2004;13(suppl 1):I50-I70.
8. Cook EH Jr, Stein MA, Krasowski MD, Cox NJ, Olkon DM, Kieffer JE, Leventhal BL. Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet. 1995;56:993-998.
9. Gill M, Daly G, Heron S, Hawi Z, Fitzgerald M. Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism. Mol Psychiatry. 1997;2:311-313.
10. Waldman ID, Rowe DC, Abramowitz A, Kozel ST, Mohr JH, Sherman SL, Cleveland HH, Sanders ML, Gard JM, Stever C. Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children. Am J Hum Genet. 1998;63:1767-1776.
11. Daly G, Hawi Z, Fitzgerald M, Gill M. Mapping susceptibility loci in attention deficit hyperactivity disorder. Mol Psychiatry. 1999;4:192-196.
12. Holmes J, Payton A, Barrett JM, Hever T, Fitzpatrick H, Trumper AL, Harrington R, McGuffin P, Ollier W, Worthington J, Thapar A. A family-based study and case-control association study of the dopamine D4 receptor gene and dopamine transporter gene in attention deficit hyperactivity disorder. Mol Psychiatry. 2000;5:523-530.
13. Roman T, Schmitz M, Polanczyk G, Eizirik M, Rohde LA, Hutz MH. Attention-deficit hyperactivity disorder. Am J Med Genet. 2001;105:471-478.
14. Todd RD, Jong YJ, Lobos EA, Reich W, Heath AC, Neuman RJ. No association of the dopamine transporter gene 3′ VNTR polymorphism with ADHD subtypes in a population sample of twins. Am J Med Genet. 2001;105:745-748.
15. Curran S, Mill J, Tahir E, Kent L, Richards S, Gould A, Huckett L, Sharp J, Batten C, Fernando S, Ozbay F, Yazgan Y, Simonoff E, Thompson M, Taylor E, Asherson P. Association study of a dopamine transporter polymorphism and attention deficit hyperactivity disorder in UK and Turkish samples. Mol Psychiatry. 2001;6:425-428.
16. Barr CL, Xu C, Kroft J, Feng Y, Wigg K, Zai G, Tannock R, Schachar R, Malone M, Roberts W, Nothen MM, Grunhage F, Vandenbergh DJ, Uhl G, Sunohara G, King N, Kennedy JL. Haplotype study of three polymorphisms at the dopamine transporter locus confirms linkage to attention-deficit/hyperactivity disorder. Biol Psychiatry. 2001;49:333-339.
17. Muglia P, Jain U, Inkster B, Kennedy JL. A quantitative trait locus analysis analysis of the dopamine transport gene in adults with ADHD. Neuropsychopharmacology. 2002;27:655-662.
18. Chen CK, Chen SL, Mill J, Huang YS, Lin SK, Curran S, Purcell S, Sham P, Asherson P. The dopamine transporter gene is associated with attention deficit hyperactivity disorder in a Taiwanese sample. Mol Psychiatry. 2003;8:393-396.
19. Kustanovich V, Ishii J, Crawford L, Yang M, McGough JJ, McCracken JT, Smalley SL, Nelson SF. Transmission disequilibrium testing of dopamine-related candidate gene polymorphisms in ADHD: confirmation of association of ADHD with DRD4 and DRD5. Mol Psychiatry. 2004;9:711-717.
20. Cornish KM, Manly T, Savage R, Swanson J, Morisano D, Butler N, Grant C, Cross D, Bentley L, Hollis CP. Association of the dopamine transporter (DAT1) 10/10-repeat genotype with ADHD symptoms and response inhibition in a general population sample. Mol Psychiatry. 2005;10:686-698.
21. Mill J, Xu X, Ronald A, Curran S, Price T, Knight J, Craig I, Sham P, Plomin R, Asherson P. Quantitative trait locus analysis of candidate gene alleles associated with attention deficit hyperactivity disorder (ADHD) in five genes: DRD4, DAT1, DRD5, SNAP-25, and 5HT1B. Am J Med Genet B Neuropsychiatr Genet. 2005;133:68-73.
22. Kahn RS, Khoury J, Nichols WC, Lanphear BP. Role of dopamine transporter genotype and maternal prenatal smoking in childhood hyperactivity-impulsive, inattentive, and oppositional behaviors. J Pediatr. 2003;143:104-110.
23. Loo SK, Specter E, Smolen A, Hopfer C, Teale PD, Reite ML. Functional effects of the DAT1 polymorphism on EEG measures in ADHD. J Am Acad Child Adolesc Psychiatry. 2003;42:986-993.
24. Roman T, Rohde LA, Hutz MH. Polymorphisms of the dopamine transporter gene: influence on response to methylphenidate in attention deficit- hyperactivity disorder. Am J Pharmacogenomics. 2004;4:83-92.
25. Kirley A, Lowe N, Hawi Z, Mullins C, Daly G, Waldman I, McCarron M, O'Donnell D, Fitzgerald M, Gill M. Association of the 480 bp DAT1 allele with methylphenidate response in a sample of Irish children with ADHD. Am J Med Genet B Neuropsychiatr Genet. 2003;121:50-54.
26. Rohde LA, Roman T, Szobot C, Cunha RD, Hutz MH, Biederman J. Dopamine transporter gene, response to methylphenidate and cerebral blood flow in attention-deficit/hyperactivity disorder: a pilot study. Synapse. 2003;48:87-89.
27. Winsberg BG, Comings DE. Association of the dopamine transporter gene (DAT1) with poor methylphenidate response. J Am Acad Child Adolesc Psychiatry. 1999;38:1474-1477.
28. Galili-Weisstub E, Levy S, Frisch A, Gross-Tsur V, Michaelovsky E, Kosov A, Meltzer A, Goltser GT, Serretti A, Cusin C, Darvasi A, Inbar E, Weizman A, Segman RH. Dopamine transporter haplotype and attention-deficit hyperactivity disorder. Mol Psychiatry. 2005;10:617-618.
29. Hawi Z, Lowe N, Kirley A, Gruenhage F, Nothen M, Greenwood T, Kelsoe J, Fitzgerald M, Gill M. Linkage disequilibrium mapping at DAT1, DRD5 and DBH narrows the search for ADHD susceptibility alleles at these loci. Mol Psychiatry. 2003;8:299-308.
30. Caspi A, McClay J, Moffitt TE, Mill J, Martin J, Craig IW, Taylor A, Poulton R. Role of genotype in the cycle of violence in maltreated children. Science. 2002;297:851-854.
31. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, McClay J, Mill J, Martin J, Braithwaite A, Poulton R. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science. 2003;301:386-389.
32. Grabe HJ, Lange M, Wolff B, Volzke H, Lucht M, Freyberger HJ, John U, Cascorbi I. Mental and physical distress is medulated by a polymorphism in the 5-HT transporter gene interacting with social stressors and chronic disease burden. Mol Psychiatry. 2005;10:220-224.
33. Mick E, Biederman J, Faraone SV, Sayer J, Kleinman S. Case-control study of attention-deficit hyperactivity disorder and maternal smoking, alcohol use, and drug use during pregnancy. J Am Acad Child Adolesc Psychiatry. 2002;41:378-385.
34. Peris TS, Hinshaw SP. Family dynamics and preadolescent girls with ADHD: the relationship between expressed emotion, ADHD symptomatology, and comorbid disruptive behavior. J Child Psychol Psychiatry. 2003;44:1177-1190.
35. Angold A, Prendergast M, Cox A, Harrington R, Simonoff E, Rutter M. The Child and Adolescent Psychiatric Assessment (CAPA). Psychol Med. 1995;25:739-753.
36. Conners CK. The Conners Rating Scale: Instruments for the Assessments of Childhood Psychopathology. Durham, NC: Duke University; 1995.
37. Curran S, Newman S, Taylor E, Asherson P. HYPESCHEME: an operational criteria checklist and minimum data set for molecular genetic studies of attention deficit and hyperactivity disorders. Am J Med Genet. 2000;96:244-250.
38. Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, Williamson D, Ryan N. Schedule for Affective Disorders and Schizophrenia for School-Age Children - Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry. 1997;36:980-988.
39. Greenwood TA, Alexander M, Keck PE, McElroy S, Sadovnick AD, Remick RA, Kelsoe JR. Evidence for linkage disequilibrium between the dopamine transporter and bipolar disorder. Am J Med Genet. 2001;105:145-151.
40. Devlin B, Risch N. A comparison of linkage disequilibrium measures for finescale mapping. Genomics. 1995;29:311-322.
41. Mill J, Asherson P, Browes C, D'Souza U, Craig I. Expression of the dopamine transporter gene is regulated by the 3′ UTR VNTR: evidence from brain and lymphocytes using quantitative RT-PCR. Am J Med Genet. 2002;114:975-979.
42. Dougherty DD, Bonab AA, Spencer TJ, Rauch SL, Madras BK, Fischman AJ. Dopamine transporter density in patients with attention deficit hyperactivity disorder. Lancet. 1999;354:2132-2133.
43. 99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment. Eur J Nucl Med. 2000;27:1518-1524.
44. Krause KH, Dresel SH, Krause J, Kung HF, Tatsch K. Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography. Neurosci Lett. 2000;285:107-110.
45. Heinz A, Goldman D, James DW, Palmour R, Hommer D, Gorey JG, Lee KS, Linnoila M, Weinberger DR. Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology. 2000;22:133-139.
46. Jacobsen LK, Staley JK, Zoghbi SS, Seibyl JP, Kosten TR, Innis RB, Gelernter J. Prediction of dopamine transporter binding availability by genotype: a preliminary report. Am J Psychiatry. 2000;157:1700-1703.
47. Martinez D, Gelernter J, Abi-Dargham A, van Dyck CH, Kegeles L, Innis RB, Laruelle M. The variable number of tandem repeats polymorphism of the dopamine transporter gene is not associated with significant change in dopamine transporter phenotype in humans. Neuropsychopharmacology. 2001;24:553-560.
48. van Dyck CH, Quinlan DM, Cretella LM, Staley JK, Malison RT, Baldwin RM, Seibyl JP, Innis RB. Unaltered dopamine transporter availability in adult attention deficit hyperactivity disorder. Am J Psychiatry. 2002;159:309-312.
49. Fuke S, Suo S, Takahashi N, Koike H, Sasagawa N, Ishiura S. The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression. Pharmacogenomics J. 2001;1:152-156.
50. Miller GM, Madras BK. Polymorphisms in the 3′-untranslated region of human and monkey dopamine transporter genes affect reporter gene expression. Mol Psychiatry. 2002;7:44-55.
51. Mill J, Asherson P, Craig I, D'Souza UM. Transient expression analysis of allelic variants of a VNTR in the dopamine transporter gene (DAT1). BMC Genet. 2005;6:3.
52. Greenwood TA, Kelsoe JR. Promoter and intronic variants affect the transcriptional regulation of the human dopamine transporter gene. Genomics. 2003;82:511-520.
53. Linnet KM, Dalsgaard S, Obel C, Wisborg K, Henriksen TB, Rodriguez A, Kotimaa A, Moilanen I, Thomsen PH, Olsen J, Jarvelin MR. Maternal lifestyle factors in pregnancy risk of attention deficit hyperactivity disorder and associated behaviors: review of the current evidence. Am J Psychiatry. 2003;160:1028-1040.
54. Coles CD, Platzman KA, Raskind-Hood CL, Brown RT, Falek A, Smith IE. A comparison of children affected by prenatal alcohol exposure and attention deficit, hyperactivity disorder. Alcohol Clin Exp Res. 1997;21:150-161.
55. Hill SY, Lowers L, Locke-Wellman J, Shen SA. Maternal smoking and drinking during pregnancy and the risk for child and adolescent psychiatric disorders. J Stud Alcohol. 2000;61:661-668.
56. Streissguth AP, Barr HM, Sampson PD, Bookstein FL. Prenatal alcohol and offspring development: the first fourteen years. Drug Alcohol Depend. 1994;36:89-99.
57. Brown RT, Coles CD, Smith IE, Platzman KA, Silverstein J, Erickson S, Falek A. Effects of prenatal alcohol exposure at school age, II: attention and behavior. Neurotoxicol Teratol. 1991;13:369-376.
58. Delaney-Black V, Covington C, Templin T, Ager J, Nordstrom-Klee B, Martier S, Leddick L, Czerwinski RH, Sokol RJ. Teacher-assessed behavior of children prenatally exposed to cocaine. Pediatrics. 2000;106:782-791.
59. Choong K, Shen R. Prenatal ethanol exposure alters the postnatal development of the spontaneous electrical activity of dopamine neurons in the ventral tegmental area. Neuroscience. 2004;126:1083-1091.
60. Druse MJ, Tajuddin N, Kuo A, Connerty M. Effects of in utero ethanol exposure on the developing dopaminergic system in rats. J Neurosci Res. 1990;27:233-240.
61. Boggan WO, Xu W, Shepherd CL, Middaugh LD. Effects of prenatal ethanol exposure on dopamine systems in C57BL/6J mice. Neurotoxicol Teratol. 1996;18:41-48.
62. Shen RY, Hannigan JH, Kapatos G. Prenatal ethanol reduces the activity of adult midbrain dopamine neurons. Alcohol Clin Exp Res. 1999;23:1801-1807.
63. Mayfield RD, Maiya R, Keller D, Zahniser NR. Ethanol potentiates the function of the human dopamine transporter expressed in Xenopus oocytes. J Neurochem. 2001;79:1070-1079.
64. Maiya R, Buck KJ, Harris RA, Mayfield RD. Ethanol-sensitive sites on the human dopamine transporter. J Biol Chem. 2002;277:30724-30729.
65. Hausknecht KA, Acheson A, Farrar AM, Kieres AK, Shen RY, Richards JB, Sabol KE. Prenatal alcohol exposure causes attention deficits in male rats. Behav Neurosci. 2005;119:302-310.